Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

X-Linked Retinoschisis With Point Mutations in the XLRS1Gene

X-Linked Retinoschisis With Point Mutations in the XLRS1Gene BackgroundX-linked retinoschisis (XLRS) is a relatively rare vitreoretinal dystrophy that causes visual loss in young men. Recently, a gene responsible for this disease, designated XLRS1, was identified, and several deleterious gene mutations were reported.ObjectiveTo analyze Japanese patients clinically diagnosed as having XLRS formutational changes in the XLRS1gene.MethodsTen patients with XLRS underwent full ophthalmologic examination, including slitlamp biomicroscopy and dilated funduscopy. Genomic DNA was isolated from leukocytes, and all exons of the XLRS1gene were amplified by polymerase chain reaction and analyzed using a direct sequencing method.ResultsPoint mutations in the XLRS1gene were identified in all 10 patients. The mutations were identical in each of 2 pairs of brothers. Six of the point mutations represented missense mutations, 1 was a nonsense mutation, and 1 was a frameshift mutation. Five of the mutations are newly reported herein.ConclusionsThe discovery of new point mutations in this study increases the available information regarding the spectrum of genetic abnormalities and clinical manifestations of XLRS. However, the limited data failed to reveal a correlation between mutation and disease phenotype.Clinical RelevanceIdentification of mutations in the XLRS1gene and expanded information on clinical manifestations will facilitate early diagnosis, appropriate early therapy, and genetic counseling regarding the prognosis of XLRS.X-LINKED retinoschisis (XLRS), first described by Haasin 1898, is a relatively rare vitreoretinal dystrophy that causes visual loss in young men. Worldwide prevalence of the disease is reportedly 1:15,000 to 1:30,000,and it is characterized by perifoveal radial retinoschisis in a cartwheel-like pattern, peripheral retinoschisis with inner-leaf breaks, and "golden glistening" of the peripheral retina.The exact pathogenesis of XLRS is unknown, although histopathologic and electrophysiologic studies have shown that splitting of the retina occurs superficial to the nerve fiber layer and inner limiting membrane. Furthermore, an inherited defect has been identified that affects the innermost portion of the cytoplasm of the Müller cell,a cell necessary for neuronal growth and connectivity,resulting in failure to establish proper neuronal interactions.Electroretinography (ERG) in patients with XLRS shows a reduced b wave in most cases,whereas fluorescein angiography occasionally shows avascular areas or retinal vascular leakage, even in ophthalmoscopically normal-appearing fundi.Recently, a gene responsible for XLRS, designated XLRS1, was identified by Sauer and colleagues.The XLRS1gene is composed of 6 coding exons that span approximately 15 kilobases of genomic DNA. Subsequent mutational studiesin patients with XLRS have revealed 5 one-exon deletions, 12 splice site mutations, 11 frameshift insertions or deletions, 7 nonsense mutations, 51 missense mutations, and 1 rare mutation caused by an early Okazaki fragment sequence replacement.In the present study, 10 Japanese patients diagnosed as having XLRS based on clinical findings were examined for possible mutations in the XLRS1gene.PATIENTS AND METHODSHISTORY AND CLINICAL EXAMINATIONTen patients (from 8 Japanese families) diagnosed clinically as having XLRS were enrolled in the study. Each patient and family were interviewed extensively, followed by full ophthalmic examination, including slitlamp biomicroscopy and dilated funduscopy. Bright-flash ERG was performed on each patient. This investigational study was approved by the Osaka University Hospital Human Research Review Board, and informed consent was obtained from all participants.DNA ANALYSISTwenty milliliters of venous blood was collected from each patient. Genomic DNA was extracted from lymphocytes, and 50 ng of DNA was amplified by polymerase chain reaction with 500 nmol/L of each forward and reverse primer in an amplification mixture containing Tris-hydrochloride, 10 mmol/L, (pH 8.3), potassium chloride, 50 mmol/L, magnesium chloride, 1.5 mmol/L, deoxyribonucleoside triphosphate, 0.2 mmol/L, and Taq polymerase (AmpliTaq Gold; Perkin-Elmer, Norwalk,Conn), 0.5 U. The primer pairs, based on published sequences,amplified each exon of the XLRS1gene, including flanking introns. All exons from each patient were sequenced using a direct sequencing method. Amplified DNA was purified using a polymerase chain reaction purification kit (Qiagen GmbH, Hilden, Germany) and sequenced with an automated fluorescent DNA sequencer (ABI Prism 377; Perkin-Elmer) using a dye terminator cycle sequencing kit (Perkin-Elmer). To exclude polymorphic variants, all coding sequences were also analyzed in 100 normal X chromosomes.RESULTSClinical characteristics and ERG results of patients with XLRS are summarized in Table 1. Eight eyes of 5 patients had foveal retinoschisis, 8 eyes of 5 patients had peripheral retinoschisis, 3 eyes of 3 patients had chorioretinal degeneration, 2 eyes of 2 patients had bull's-eye macular lesions, and 2 eyes of 1 patient had perifoveal round cysts. The ERG testing revealed a negative configuration in 18 eyes of 10 patients and an extinguished ERG in 2 eyes of 2 patients. The fundus photographs of 2 patients are shown in Figure 1, demonstrating the clinical variation observed in patients with XLRS in this study. Figure 1, left, shows a classic bull's-eye pattern in the left macula of patient E1, whereas Figure 1, right, shows foveal retinoschisis and vitreous veils in the right eye of patient F1. Seven of the 10 patients (A, B, E1, E2, F1, F2, and H), including 2 pairs of brothers, had a confirmed positive family history for a male member with eye disease consistent with XLRS. The pedigrees of these families are shown in Figure 2.Table 1. Clinical Characteristics of Patients With X-Linked RetinoschisisPatient/Age*/SexBest Corrected Visual Acuity ODBest Corrected Visual Acuity OSFundus Findings and ElectroretinographyA/2 (10 mo)/MNot testedNot testedBullous retinoschisis OU, macular involvement OS, reduced b wave OUB/32 (29)/M20/10020/100Peripheral and foveal retinoschisis OU, reduced b wave OUC/12 (2)/M20/25020/20Peripheral retinoschisis with large inner retinal breaks OU, reduced b wave OUD/49 (40)/M20/20020/200Perifoveal round cysts OU, reduced b wave OUE1†/58 (49)/M20/3020/200Chorioretinal macular degeneration OD, bull's-eye macular lesion OS, reduced b wave OUE2†/55 (46)/M20/200Light perceptionTurbid, flat fovea OD, diffuse pigmentary chorioretinal degeneration OS, reduced b wave OD, extinguished electroretinography OSF1‡/13 (8)/M20/20020/200Foveal retinoschisis with vitreous veils OU, reduced b wave OUF2‡/11 (6)/M20/5020/50Foveal retinoschisis with vitreous veils OU, reduced b wave OUG/25 (15)/M20/5020/150Foveal and peripheral retinoschisis OD, bull's-eye macular lesion, diffuse chorioretinal degeneration OS, reduced b wave OD, extinguished electroretinography OSH/18 (11 mo)/M20/40020/50Peripheral retinoschisis with a large inner retinal break, macular degeneration OD, peripheral golden reflex, foveal retinoschisis OS, reduced b wave OU*Age in years (unless otherwise indicated) at time of study, with age at first diagnosis in parentheses.†Brothers from the same family, previously reported by Wakabayashi et al.19‡Brothers from the same family.Figure 1.Left, Classic bull's-eye pattern of retinoschisis in the left eye of patient E1. Right, Foveal retinoschisis and vitreous veils in the left eye of patient F1.Figure 2.Pedigrees of families A, B, E, F, and H with X-linked retinoschisis (XLRS). Solid symbols indicate individuals with XLRS as diagnosed by clinical examination; open symbols, unaffected individuals.Results of DNA analysis of the XLRS1gene in the 10 patients are shown in Table 2. Direct sequencing revealed 8 different point mutations in the 10 patients. Both pairs of brothers had identical mutations. Six of the 8 point mutations represented missense mutations, 1 represented a nonsense mutation, and 1 represented a frameshift mutation. These mutations were not detected in 100 normal X chromosomes.Table 2. Mutations Detected in the XLRS1GenePatientExonMutation*Nucleotide ChangeA4W92C†G276CB5C110XT330AC6R182C‡C544TD4G109EG326AE1, E26R200CC598TF1, F26R197PG590CG4Frameshift195delTH6P192S§C574T*Mutations are named according to standard nomenclature.†Same mutation as Hotta et al15reported.‡Same mutation as the Retinoschisis Consortium14reported.§Same mutation as Sauer et al13and the Retinoschisis Consortium14reported.COMMENTX-linked retinoschisis has a variable phenotypic expression. Although foveal retinoschisis is said to be characteristic of XLRS, its rate of appearance is reportedly only 15% in patients 40 to 70 years of age.In the present study, 4 (40%) of 10 patients showed foveal retinoschisis by clinical examination. Other posterior pole findings may include albipunctatus-like flecks—as reported by Boisdequin and colleaguesand said to be an important finding in the early stages of XLRS in young men—and bull's-eye macular lesion, as reported by Wakabayashi and colleagues.However, XLRS is a difficult disease to diagnose based on ophthalmoscopic features alone. Ancillary testing, such as ERG and fluorescein angiography, may be helpful, although its findings in XLRS also vary considerably. In particular, the ERG may reveal a reduced b wave with single bright-flash stimulus or a negative rectangular configuration with repetitive rectangular photopic stimuli.In the present study, a negative response was revealed by flash ERG in all patients. Miyake and colleaguesreported that, despite a reduced b wave, the a wave was normal in early stages of XLRS, whereas later stages were associated with a reduction in the a wave as well. They suggested that photoreceptors were not the primary target in the pathogenesis of this disease. However, in our study, patient G showed reduction of the a and b waves in the left eye, despite being only 25 years of age. His left eye was noted to have diffuse chorioretinal atrophy from childhood. It is possible that early progression of disease in this patient is related to the particular frameshift mutation that he had in his XLRS1gene. However, the patient who had a nonsense mutation (patient B) did not have a particularly severe phenotype compared with the others. In our study, significant phenotype-genotype correlation was not identified.Following identification of the XLRS1gene,several mutations of the gene have been reported.In the present study, we were able to identify 8 different point mutations, 5 of which have never, to our knowledge, been previously reported. Mutations in the XLRS1gene in Japanese patients have been previously reported by Hotta and colleagues,who identified 6 missense mutations and 1 nonsense mutation; only 1 of these (the W92C mutation) was identified in our study. Hotta and colleagues suggested that the E72K mutation may be common among Japanese patients; however, none of our 10 patients had this mutation. The Retinoschisis Consortiumreported a "hotspot" at a stretch of 6 C residues (positions 574-579). Our study revealed 1 missense mutation (C574T) in this location. Approximately 100 mutations in the XLRS1gene have been reported, which are mainly located in exons 4, 5, and 6, although they occur in other exons as well. A definitive phenotype-genotype correlation has not been identified to date. This suggests that the entire XLRS1 protein may play an important role in this disease. Interestingly, 6 of the mutations we found involved codon 101-203, which is a highly preserved domain with the discoidin motif, a protein considered to function in phospholipid binding and cell-cell interactions on membrane surfaces.Direct sequencing succeeded in identifying mutations in the XLRS1gene in all 10 patients. It may be expected that the accumulation of genetic information using methods such as direct sequencing will reveal further insight into the pathogenesis and clinical spectrum of XLRS. Furthermore, it is hoped that identifying various mutations in the XLRS1gene will lead to improved early diagnosis and appropriate early therapy where possible, depending on the phenotype. Finally, disease classification, combined with long-term studies in prognosis, will aid the clinician in providing genetic counseling for affected patients and families.JHaasUeber das zusammenvorkommen von veraenderungen der retina und choroidea.Arch Augenheilkd.1898;37:343-348.Ade la ChapelleTAlitaloHForsiusX-linked juvenile retinoschisis.In: Wright A, Jay B, eds. Molecular Genetics of Inherited Eye Disorders. Chur, Switzerland: Harwood Academic; 1994:339-357.MJvan SchooneveldYMiyakeFundus albipunctatus-like lesion in juvenile retinoschisis.Br J Ophthalmol.1994;78:659-661.MYanoffEKRahnLEZimmermanHistopathology of juvenile retinoschisis.Arch Ophthalmol.1968;79:49-53.WAManschotPathology of hereditary juvenile retinoschisis.Arch Ophthalmol.1972;88:131-137.GPCondonSBrownsteinNWangCongenital hereditary (juvenile X-linked) retinoschisis: histopathologic and ultrastructural findings in three eyes.Arch Ophthalmol.1986;104:576-583.NSPeacheyGAFishmanDJDerlackiPsychophysical and electroretinographic findings in X-linked juvenile retinoschisis.Arch Ophthalmol.1987;105:513-516.JBSheffieldHPLiInteractions among cells of the developing neural retina in vitro.Am Zool.1987;27:145-159.IJKljavinTARehMüller cells are a preferred substate for in vitro neurite extention by rod photoreceptor cells.J Neurosci.1991;11:2985-2994.GBArdenMBGorinPJPolkinghorneDetection of the carrier state of X-linked retinoschisis.Am J Ophthalmol.1988;105:590-595.TTaninoOKatsumiTHiroseElectrophysiological similarities between two eyes with X-linked recessive retinoschisis.Doc Ophthalmol.1985;60:149-161.JGreenLJampolVascular opacification and leakage in X-linked juvenile retinoschisis.Br J Ophthalmol.1979;63:368-373.CGSauerAGehrigRWarneke-WittstockPositional cloning of the gene associated with X-linked juvenile retinoschisis.Nat Genet.1997;17:164-170.The Retinoschisis ConsortiumFunctional implications of the spectrum of mutations found in 234 cases with X-linked juvenile retinoschisis (XLRS).Hum Mol Genet.1998;7:1185-1192.YHottaKFujikiMHayakawaJapanese juvenile retinoschisis is caused by mutations of the XLRS gene.Hum Genet.1998;103:142-144.IRRodriguezKMazurukCJawarskiNovel mutations in the XLRS1gene may be caused by early Okazaki fragment sequence replacement.Invest Ophthalmol Vis Sci.1998;39:1736-1739.NDLGeorgeJRWYatesATMooreClinical features in affected males with X-linked retinoschisis.Arch Ophthalmol.1996;114:274-280.DBoisdequinPCroughsPRegnierLe rétinoschisis.Bull Soc Belge Ophthalmol.1981;198:51-89.KWakabayashiANishimuraTOkamotoBull's eye maculopathy was associated with X-linked juvenile retinoschisis.Jpn J Clin Ophthalmol.1990;44:1195-1199.DYonemuraKKawasakiKWakabayashiEOG application for Stargardt's disease and X-linked juvenile retinoschisis.Doc Ophthalmol.1983;37:115-120.YMiyakeNShiroyamaIOtaFocal macular electroretinogram in X-linked congenital retinoschisis.Invest Ophthalmol Vis Sci.1993;34:512-515.WRSpringerDNCooperSHBarondesDiscoidin I is implicated in cell-substratum attachment and ordered cell migration of Dictyostelium discoideumand resembles fibronectin.Cell.1984;39:557-564.Accepted for publication August 26, 1999.This work was supported in part by grant-in-aid 10671643 for Scientific Research from the Ministry of Education, Culture, and Science of Japan (Dr Yamamoto) and a Grant for Research on Eye and Ear Science, Immunology, Allergy, and Organ Transplantation from the Ministry of Health and Welfare (Drs Yamamoto and Tano), Tokyo, Japan.Reprints: Shuji Yamamoto, MD, Department of Ophthalmology and Visual Science, Osaka University Medical School (E7), 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan (e-mail: yamamoto@ophthal.med.osaka-u.ac.jp). http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Ophthalmology American Medical Association

Loading next page...
 
/lp/american-medical-association/x-linked-retinoschisis-with-point-mutations-in-the-xlrs1gene-HXI0h0nXjf
Publisher
American Medical Association
Copyright
Copyright 2000 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6165
eISSN
2168-6173
DOI
10.1001/archopht.118.1.93
Publisher site
See Article on Publisher Site

Abstract

BackgroundX-linked retinoschisis (XLRS) is a relatively rare vitreoretinal dystrophy that causes visual loss in young men. Recently, a gene responsible for this disease, designated XLRS1, was identified, and several deleterious gene mutations were reported.ObjectiveTo analyze Japanese patients clinically diagnosed as having XLRS formutational changes in the XLRS1gene.MethodsTen patients with XLRS underwent full ophthalmologic examination, including slitlamp biomicroscopy and dilated funduscopy. Genomic DNA was isolated from leukocytes, and all exons of the XLRS1gene were amplified by polymerase chain reaction and analyzed using a direct sequencing method.ResultsPoint mutations in the XLRS1gene were identified in all 10 patients. The mutations were identical in each of 2 pairs of brothers. Six of the point mutations represented missense mutations, 1 was a nonsense mutation, and 1 was a frameshift mutation. Five of the mutations are newly reported herein.ConclusionsThe discovery of new point mutations in this study increases the available information regarding the spectrum of genetic abnormalities and clinical manifestations of XLRS. However, the limited data failed to reveal a correlation between mutation and disease phenotype.Clinical RelevanceIdentification of mutations in the XLRS1gene and expanded information on clinical manifestations will facilitate early diagnosis, appropriate early therapy, and genetic counseling regarding the prognosis of XLRS.X-LINKED retinoschisis (XLRS), first described by Haasin 1898, is a relatively rare vitreoretinal dystrophy that causes visual loss in young men. Worldwide prevalence of the disease is reportedly 1:15,000 to 1:30,000,and it is characterized by perifoveal radial retinoschisis in a cartwheel-like pattern, peripheral retinoschisis with inner-leaf breaks, and "golden glistening" of the peripheral retina.The exact pathogenesis of XLRS is unknown, although histopathologic and electrophysiologic studies have shown that splitting of the retina occurs superficial to the nerve fiber layer and inner limiting membrane. Furthermore, an inherited defect has been identified that affects the innermost portion of the cytoplasm of the Müller cell,a cell necessary for neuronal growth and connectivity,resulting in failure to establish proper neuronal interactions.Electroretinography (ERG) in patients with XLRS shows a reduced b wave in most cases,whereas fluorescein angiography occasionally shows avascular areas or retinal vascular leakage, even in ophthalmoscopically normal-appearing fundi.Recently, a gene responsible for XLRS, designated XLRS1, was identified by Sauer and colleagues.The XLRS1gene is composed of 6 coding exons that span approximately 15 kilobases of genomic DNA. Subsequent mutational studiesin patients with XLRS have revealed 5 one-exon deletions, 12 splice site mutations, 11 frameshift insertions or deletions, 7 nonsense mutations, 51 missense mutations, and 1 rare mutation caused by an early Okazaki fragment sequence replacement.In the present study, 10 Japanese patients diagnosed as having XLRS based on clinical findings were examined for possible mutations in the XLRS1gene.PATIENTS AND METHODSHISTORY AND CLINICAL EXAMINATIONTen patients (from 8 Japanese families) diagnosed clinically as having XLRS were enrolled in the study. Each patient and family were interviewed extensively, followed by full ophthalmic examination, including slitlamp biomicroscopy and dilated funduscopy. Bright-flash ERG was performed on each patient. This investigational study was approved by the Osaka University Hospital Human Research Review Board, and informed consent was obtained from all participants.DNA ANALYSISTwenty milliliters of venous blood was collected from each patient. Genomic DNA was extracted from lymphocytes, and 50 ng of DNA was amplified by polymerase chain reaction with 500 nmol/L of each forward and reverse primer in an amplification mixture containing Tris-hydrochloride, 10 mmol/L, (pH 8.3), potassium chloride, 50 mmol/L, magnesium chloride, 1.5 mmol/L, deoxyribonucleoside triphosphate, 0.2 mmol/L, and Taq polymerase (AmpliTaq Gold; Perkin-Elmer, Norwalk,Conn), 0.5 U. The primer pairs, based on published sequences,amplified each exon of the XLRS1gene, including flanking introns. All exons from each patient were sequenced using a direct sequencing method. Amplified DNA was purified using a polymerase chain reaction purification kit (Qiagen GmbH, Hilden, Germany) and sequenced with an automated fluorescent DNA sequencer (ABI Prism 377; Perkin-Elmer) using a dye terminator cycle sequencing kit (Perkin-Elmer). To exclude polymorphic variants, all coding sequences were also analyzed in 100 normal X chromosomes.RESULTSClinical characteristics and ERG results of patients with XLRS are summarized in Table 1. Eight eyes of 5 patients had foveal retinoschisis, 8 eyes of 5 patients had peripheral retinoschisis, 3 eyes of 3 patients had chorioretinal degeneration, 2 eyes of 2 patients had bull's-eye macular lesions, and 2 eyes of 1 patient had perifoveal round cysts. The ERG testing revealed a negative configuration in 18 eyes of 10 patients and an extinguished ERG in 2 eyes of 2 patients. The fundus photographs of 2 patients are shown in Figure 1, demonstrating the clinical variation observed in patients with XLRS in this study. Figure 1, left, shows a classic bull's-eye pattern in the left macula of patient E1, whereas Figure 1, right, shows foveal retinoschisis and vitreous veils in the right eye of patient F1. Seven of the 10 patients (A, B, E1, E2, F1, F2, and H), including 2 pairs of brothers, had a confirmed positive family history for a male member with eye disease consistent with XLRS. The pedigrees of these families are shown in Figure 2.Table 1. Clinical Characteristics of Patients With X-Linked RetinoschisisPatient/Age*/SexBest Corrected Visual Acuity ODBest Corrected Visual Acuity OSFundus Findings and ElectroretinographyA/2 (10 mo)/MNot testedNot testedBullous retinoschisis OU, macular involvement OS, reduced b wave OUB/32 (29)/M20/10020/100Peripheral and foveal retinoschisis OU, reduced b wave OUC/12 (2)/M20/25020/20Peripheral retinoschisis with large inner retinal breaks OU, reduced b wave OUD/49 (40)/M20/20020/200Perifoveal round cysts OU, reduced b wave OUE1†/58 (49)/M20/3020/200Chorioretinal macular degeneration OD, bull's-eye macular lesion OS, reduced b wave OUE2†/55 (46)/M20/200Light perceptionTurbid, flat fovea OD, diffuse pigmentary chorioretinal degeneration OS, reduced b wave OD, extinguished electroretinography OSF1‡/13 (8)/M20/20020/200Foveal retinoschisis with vitreous veils OU, reduced b wave OUF2‡/11 (6)/M20/5020/50Foveal retinoschisis with vitreous veils OU, reduced b wave OUG/25 (15)/M20/5020/150Foveal and peripheral retinoschisis OD, bull's-eye macular lesion, diffuse chorioretinal degeneration OS, reduced b wave OD, extinguished electroretinography OSH/18 (11 mo)/M20/40020/50Peripheral retinoschisis with a large inner retinal break, macular degeneration OD, peripheral golden reflex, foveal retinoschisis OS, reduced b wave OU*Age in years (unless otherwise indicated) at time of study, with age at first diagnosis in parentheses.†Brothers from the same family, previously reported by Wakabayashi et al.19‡Brothers from the same family.Figure 1.Left, Classic bull's-eye pattern of retinoschisis in the left eye of patient E1. Right, Foveal retinoschisis and vitreous veils in the left eye of patient F1.Figure 2.Pedigrees of families A, B, E, F, and H with X-linked retinoschisis (XLRS). Solid symbols indicate individuals with XLRS as diagnosed by clinical examination; open symbols, unaffected individuals.Results of DNA analysis of the XLRS1gene in the 10 patients are shown in Table 2. Direct sequencing revealed 8 different point mutations in the 10 patients. Both pairs of brothers had identical mutations. Six of the 8 point mutations represented missense mutations, 1 represented a nonsense mutation, and 1 represented a frameshift mutation. These mutations were not detected in 100 normal X chromosomes.Table 2. Mutations Detected in the XLRS1GenePatientExonMutation*Nucleotide ChangeA4W92C†G276CB5C110XT330AC6R182C‡C544TD4G109EG326AE1, E26R200CC598TF1, F26R197PG590CG4Frameshift195delTH6P192S§C574T*Mutations are named according to standard nomenclature.†Same mutation as Hotta et al15reported.‡Same mutation as the Retinoschisis Consortium14reported.§Same mutation as Sauer et al13and the Retinoschisis Consortium14reported.COMMENTX-linked retinoschisis has a variable phenotypic expression. Although foveal retinoschisis is said to be characteristic of XLRS, its rate of appearance is reportedly only 15% in patients 40 to 70 years of age.In the present study, 4 (40%) of 10 patients showed foveal retinoschisis by clinical examination. Other posterior pole findings may include albipunctatus-like flecks—as reported by Boisdequin and colleaguesand said to be an important finding in the early stages of XLRS in young men—and bull's-eye macular lesion, as reported by Wakabayashi and colleagues.However, XLRS is a difficult disease to diagnose based on ophthalmoscopic features alone. Ancillary testing, such as ERG and fluorescein angiography, may be helpful, although its findings in XLRS also vary considerably. In particular, the ERG may reveal a reduced b wave with single bright-flash stimulus or a negative rectangular configuration with repetitive rectangular photopic stimuli.In the present study, a negative response was revealed by flash ERG in all patients. Miyake and colleaguesreported that, despite a reduced b wave, the a wave was normal in early stages of XLRS, whereas later stages were associated with a reduction in the a wave as well. They suggested that photoreceptors were not the primary target in the pathogenesis of this disease. However, in our study, patient G showed reduction of the a and b waves in the left eye, despite being only 25 years of age. His left eye was noted to have diffuse chorioretinal atrophy from childhood. It is possible that early progression of disease in this patient is related to the particular frameshift mutation that he had in his XLRS1gene. However, the patient who had a nonsense mutation (patient B) did not have a particularly severe phenotype compared with the others. In our study, significant phenotype-genotype correlation was not identified.Following identification of the XLRS1gene,several mutations of the gene have been reported.In the present study, we were able to identify 8 different point mutations, 5 of which have never, to our knowledge, been previously reported. Mutations in the XLRS1gene in Japanese patients have been previously reported by Hotta and colleagues,who identified 6 missense mutations and 1 nonsense mutation; only 1 of these (the W92C mutation) was identified in our study. Hotta and colleagues suggested that the E72K mutation may be common among Japanese patients; however, none of our 10 patients had this mutation. The Retinoschisis Consortiumreported a "hotspot" at a stretch of 6 C residues (positions 574-579). Our study revealed 1 missense mutation (C574T) in this location. Approximately 100 mutations in the XLRS1gene have been reported, which are mainly located in exons 4, 5, and 6, although they occur in other exons as well. A definitive phenotype-genotype correlation has not been identified to date. This suggests that the entire XLRS1 protein may play an important role in this disease. Interestingly, 6 of the mutations we found involved codon 101-203, which is a highly preserved domain with the discoidin motif, a protein considered to function in phospholipid binding and cell-cell interactions on membrane surfaces.Direct sequencing succeeded in identifying mutations in the XLRS1gene in all 10 patients. It may be expected that the accumulation of genetic information using methods such as direct sequencing will reveal further insight into the pathogenesis and clinical spectrum of XLRS. Furthermore, it is hoped that identifying various mutations in the XLRS1gene will lead to improved early diagnosis and appropriate early therapy where possible, depending on the phenotype. Finally, disease classification, combined with long-term studies in prognosis, will aid the clinician in providing genetic counseling for affected patients and families.JHaasUeber das zusammenvorkommen von veraenderungen der retina und choroidea.Arch Augenheilkd.1898;37:343-348.Ade la ChapelleTAlitaloHForsiusX-linked juvenile retinoschisis.In: Wright A, Jay B, eds. Molecular Genetics of Inherited Eye Disorders. Chur, Switzerland: Harwood Academic; 1994:339-357.MJvan SchooneveldYMiyakeFundus albipunctatus-like lesion in juvenile retinoschisis.Br J Ophthalmol.1994;78:659-661.MYanoffEKRahnLEZimmermanHistopathology of juvenile retinoschisis.Arch Ophthalmol.1968;79:49-53.WAManschotPathology of hereditary juvenile retinoschisis.Arch Ophthalmol.1972;88:131-137.GPCondonSBrownsteinNWangCongenital hereditary (juvenile X-linked) retinoschisis: histopathologic and ultrastructural findings in three eyes.Arch Ophthalmol.1986;104:576-583.NSPeacheyGAFishmanDJDerlackiPsychophysical and electroretinographic findings in X-linked juvenile retinoschisis.Arch Ophthalmol.1987;105:513-516.JBSheffieldHPLiInteractions among cells of the developing neural retina in vitro.Am Zool.1987;27:145-159.IJKljavinTARehMüller cells are a preferred substate for in vitro neurite extention by rod photoreceptor cells.J Neurosci.1991;11:2985-2994.GBArdenMBGorinPJPolkinghorneDetection of the carrier state of X-linked retinoschisis.Am J Ophthalmol.1988;105:590-595.TTaninoOKatsumiTHiroseElectrophysiological similarities between two eyes with X-linked recessive retinoschisis.Doc Ophthalmol.1985;60:149-161.JGreenLJampolVascular opacification and leakage in X-linked juvenile retinoschisis.Br J Ophthalmol.1979;63:368-373.CGSauerAGehrigRWarneke-WittstockPositional cloning of the gene associated with X-linked juvenile retinoschisis.Nat Genet.1997;17:164-170.The Retinoschisis ConsortiumFunctional implications of the spectrum of mutations found in 234 cases with X-linked juvenile retinoschisis (XLRS).Hum Mol Genet.1998;7:1185-1192.YHottaKFujikiMHayakawaJapanese juvenile retinoschisis is caused by mutations of the XLRS gene.Hum Genet.1998;103:142-144.IRRodriguezKMazurukCJawarskiNovel mutations in the XLRS1gene may be caused by early Okazaki fragment sequence replacement.Invest Ophthalmol Vis Sci.1998;39:1736-1739.NDLGeorgeJRWYatesATMooreClinical features in affected males with X-linked retinoschisis.Arch Ophthalmol.1996;114:274-280.DBoisdequinPCroughsPRegnierLe rétinoschisis.Bull Soc Belge Ophthalmol.1981;198:51-89.KWakabayashiANishimuraTOkamotoBull's eye maculopathy was associated with X-linked juvenile retinoschisis.Jpn J Clin Ophthalmol.1990;44:1195-1199.DYonemuraKKawasakiKWakabayashiEOG application for Stargardt's disease and X-linked juvenile retinoschisis.Doc Ophthalmol.1983;37:115-120.YMiyakeNShiroyamaIOtaFocal macular electroretinogram in X-linked congenital retinoschisis.Invest Ophthalmol Vis Sci.1993;34:512-515.WRSpringerDNCooperSHBarondesDiscoidin I is implicated in cell-substratum attachment and ordered cell migration of Dictyostelium discoideumand resembles fibronectin.Cell.1984;39:557-564.Accepted for publication August 26, 1999.This work was supported in part by grant-in-aid 10671643 for Scientific Research from the Ministry of Education, Culture, and Science of Japan (Dr Yamamoto) and a Grant for Research on Eye and Ear Science, Immunology, Allergy, and Organ Transplantation from the Ministry of Health and Welfare (Drs Yamamoto and Tano), Tokyo, Japan.Reprints: Shuji Yamamoto, MD, Department of Ophthalmology and Visual Science, Osaka University Medical School (E7), 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan (e-mail: yamamoto@ophthal.med.osaka-u.ac.jp).

Journal

JAMA OphthalmologyAmerican Medical Association

Published: Jan 1, 2000

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$499/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month